日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Implementing treat-to-target urate-lowering therapy during hospitalizations for gout flares

在痛风急性发作住院期间实施达标降尿酸治疗

Russell, Mark D; Ameyaw-Kyeremeh, Louise; Dell'Accio, Flora; Lapham, Heather; Head, Natalie; Stovin, Christopher; Patel, Vishit; Clarke, Benjamin D; Nagra, Deepak; Alveyn, Edward; Adas, Maryam A; Bechman, Katie; de la Puente, María A; Ellis, Benjamin; Byrne, Corrine; Patel, Rina; Rutherford, Andrew I; Cantle, Fleur; Norton, Sam; Roddy, Edward; Hudson, Joanna; Cope, Andrew P; Galloway, James B

JAK inhibitors and the risk of malignancy: a meta-analysis across disease indications

JAK抑制剂与恶性肿瘤风险:一项跨疾病适应症的荟萃分析

Russell, Mark D; Stovin, Christopher; Alveyn, Edward; Adeyemi, Olukemi; Chan, Chun Kit David; Patel, Vishit; Adas, Maryam A; Atzeni, Fabiola; Ng, Kenrick K H; Rutherford, Andrew I; Norton, Sam; Cope, Andrew P; Galloway, James B

IL-6 inhibition in the treatment of COVID-19: A meta-analysis and meta-regression

IL-6抑制剂在COVID-19治疗中的应用:一项荟萃分析和荟萃回归分析

Tharmarajah, Emmanuel; Buazon, April; Patel, Vishit; Hannah, Jennifer R; Adas, Maryam; Allen, Victoria B; Bechman, Katie; Clarke, Benjamin D; Nagra, Deepak; Norton, Sam; Russell, Mark D; Rutherford, Andrew I; Yates, Mark; Galloway, James B

EP21 Tumour necrosis factor inhibitor for the treatment of refractory extra-pulmonary disease including sarcoid arthritis and myositis

EP21 是一种肿瘤坏死因子抑制剂,用于治疗难治性肺外疾病,包括结节病性关节炎和肌炎。

Aggarwal, Aakash; Arora, Ripu Daman; Nagarkar, Nitin M; Banjare, Amit; Rampes, Sanketh; Patel, Vishit; Nagra, Deepak; Hannah, Jennifer; Galloway, James